Viewing Study NCT00628095


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-01-03 @ 6:48 PM
Study NCT ID: NCT00628095
Status: COMPLETED
Last Update Posted: 2022-04-04
First Post: 2008-02-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-04-07
Start Date Type: ACTUAL
Primary Completion Date: 2009-02-04
Primary Completion Date Type: ACTUAL
Completion Date: 2009-02-04
Completion Date Type: ACTUAL
First Submit Date: 2008-02-25
First Submit QC Date: None
Study First Post Date: 2008-03-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-01-26
Results First Submit QC Date: None
Results First Post Date: 2022-04-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2009-10-12
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2022-03-09
Last Update Post Date: 2022-04-04
Last Update Post Date Type: ACTUAL